Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Immunotherapy Combined With ChemoRadiation for Patients With High-risk Resectable Extrahepatic Cholangiocarcinoma（AICRC）

NCT06997913 is registered in ClinicalTrials.gov with Hengchao Yu as lead sponsor.

NCT NCT06997913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06997913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Immunotherapy Combined With ChemoRadiation for Patients With High-risk Resectable Extrahepatic Cholangiocarcinoma（AICRC）
Lead sponsor
Hengchao Yu
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 15, 2025
Completion date
December 30, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node metastasis, neurovascular invasion, pathology showed r1 resection